Point estimation for adaptive trial designs I: A methodological review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Point estimation for adaptive trial designs I: A methodological review

Published:2022-11-30 Issue:2 Volume:42 Page:122-145
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Robertson David S.¹^ORCID,Choodari‐Oskooei Babak²^ORCID,Dimairo Munya³^ORCID,Flight Laura³,Pallmann Philip⁴^ORCID,Jaki Thomas¹⁵^ORCID

Affiliation:

1. MRC Biostatistics Unit University of Cambridge Cambridge UK

2. MRC Clinical Trials Unit at UCL London UK

3. School of Health and Related Research (ScHARR) University of Sheffield Sheffield UK

4. Centre for Trials Research Cardiff University Cardiff UK

5. Faculty of Informatics and Data Science University of Regensburg Regensburg Germany

Funder

Health and Care Research Wales

Medical Research Council Canada

National Institute for Health Research

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9605

Reference159 articles.

1. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design

2. Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges of estimating treatment effects after a positive interim analysis;European Journal of Cancer;2024-09

2. Practical and analytical considerations when performing interim analyses in diagnostic test accuracy studies;Diagnostic and Prognostic Research;2024-08-20

3. Analysis of Nonconcurrent Controls in Adaptive Platform Trials: Separating Randomized and Nonrandomized Information;Biometrical Journal;2024-08-05

4. The impact of heterogeneity on the analysis of platform trials with normally distributed outcomes;BMC Medical Research Methodology;2024-07-30

5. Medical Statistics in Drug Development and Regulatory Approval;Advances in Bioinformatics and Biomedical Engineering;2024-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3